(Q45132140)

9 December 2017

Use of azathioprine and the risk of cancer in inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

9 December 2017

0 references

1 reference

Anders Hviid

5

0 references

Björn Pasternak

object named as

Björn Pasternak

series ordinal

1

0 references

Kjeld Schmiegelow

series ordinal

3

object named as

Kjeld Schmiegelow

1 reference

9 December 2017

Henrik Svanström

2

1 reference

PubMed ID

23514635

9 December 2017

Tine Jess

series ordinal

4

1 reference

PubMed ID

23514635

9 December 2017

language of work or name

English

0 references

publication date

20 March 2013

1 reference

American Journal of Epidemiology

9 December 2017

1 reference

9 December 2017

177

1 reference

9 December 2017

11

1 reference

9 December 2017

1296-1305

1 reference

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

9 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

European evidence-based Consensus on the management of ulcerative colitis: Current management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Inflammatory bowel disease therapies and cancer risk: where are we and where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Thiopurines, DNA damage, DNA repair and therapy-related cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

The Danish Cancer Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

The Danish National Prescription Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

A basic study design for expedited safety signal evaluation based on electronic healthcare data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Assessment of the diagnoses of Crohn's disease and ulcerative colitis in a Danish hospital information system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Intestinal inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

Infliximab, azathioprine, or combination therapy for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWS375

21 January 2018

Identifiers

DOI

10.1093/AJE/KWS375

1 reference

9 December 2017

1 reference

PubMed ID

23514635